Cardiometabolic Health Congress

NOVEMBER 14, 2024

He emphasized the evolving landscape of biomarker utility in enhancing the accuracy of HF prediction and the need for targeted interventions based on these biomarkers. He emphasized the evolving landscape of biomarker utility in enhancing the accuracy of HF prediction and the need for targeted interventions based on these biomarkers.

CME 96

CME Obesity Heart Failure Biomarkers 96

Cardiometabolic Health Congress

OCTOBER 25, 2024

Attendees dove into cutting-edge topics, including FDA updates, resistant hypertension, and cardiac biomarkers. “I Looking Ahead: The Future of Cardiorenal Metabolic Medicine For those unable to attend, on-demand access to the 19th Annual CMHC content will be available from December 2024 to December 2025. Learn more now!

CME 65

CME Innovation Education Atherosclerosis 65

CardiacWire

JUNE 19, 2024

Marea still has to prove MAR001’s performance, although in its Phase 1 trial MAR001 significantly lowered remnant cholesterol levels and improved metabolic biomarkers. Results from its current Phase 1b/2a trial is due to be completed by the end of 2024, and its Phase 2b trial is scheduled to start in early 2025.

Cholesterol 59

Cholesterol Biomarkers Risk Factors Research 59

Dr. Malcolm Kendrick

OCTOBER 30, 2024

(2022-25) Swiss Reinsurance Company: £645K China Kadoorie Biobank (2002-ongoing) AstraZeneca: $300K Bayer AG: £300K GlaxoSmithKline: £3.6M Elinogrel feasibility trial (2010-2011) Novartis: £500K EMPA-KIDNEY (2017-ongoing) Boehringer Ingelheim: £106.3M Establishing Fuwai-Oxford research centre (2010-ongoing) Merck: £1.1M

Cholesterol 145

Cholesterol Article Research Diet 145